{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:07:16Z","timestamp":1756994836143},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1975,6,1]],"date-time":"1975-06-01T00:00:00Z","timestamp":170812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Gynak."],"published-print":{"date-parts":[[1975,6]]},"DOI":"10.1007\/bf01395909","type":"journal-article","created":{"date-parts":[[2005,4,2]],"date-time":"2005-04-02T18:49:47Z","timestamp":1112467787000},"page":"85-94","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptine (CB 154) clinical response and pattern of pituitary and steroid hormones before and during therapy"],"prefix":"10.1007","volume":"218","author":[{"given":"H. J.","family":"K\ufffdnzig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H.","family":"Lose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem-32-5-619","volume":"32","author":"G. E. Abraham","year":"1971","unstructured":"Abraham, G. E., Swerdloff, R., Tulchinsky, P., Odell, W. D.: Radioimmunoassay of plasma progesterone. J. clin. Endocr.32, 619 (1971)","journal-title":"J. clin. Endocr."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bmj.3.5828.669","volume":"III","author":"G. M. Besser","year":"1972","unstructured":"Besser, G. M., Parke, L., Edwards, C. R. W., Forsyth, I. A., Zander, J.: Galactorrhea: successful treatment with reduction of plasma prolactin level by Bromergocryptine British Medical Journal, III, 669 (1972)","journal-title":"British Medical Journal"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF02137315","volume":"27","author":"E. Billeter","year":"1971","unstructured":"Billeter, E., Fl\u00fcckiger, E.: Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-alpha-ergocryptine. Experientia27, 464 (1971)","journal-title":"Experientia"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000178230","volume":"2","author":"G. D. Bryant","year":"1971","unstructured":"Bryant, G. D., Siler, T. M., Greenwood, F. C., Pasteels, J. L., Robyn, C., Hubinont, P. O.: Radioimmunoassay of a human prolactin in plasma. Hormones2, 139 (1971)","journal-title":"Hormones"},{"key":"CR5","first-page":"847","volume":"103","author":"E. Pozo Del","year":"1973","unstructured":"Del Pozo, E., Friesen, H. G., Burmeister, P.: Endocrine profile of a specific prolactine inhibitor: Br. ergocryptine (CB 154). A preliminary report. Schweiz. Med. Wschr.103, 847 (1973)","journal-title":"Schweiz. Med. Wschr."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jcem-35-5-768","volume":"35","author":"E. Pozo Del","year":"1972","unstructured":"Del Pozo, E., Brun, R., Varga, L., Friesen, H.: The inhibition of prolactin secretion in man by CB 154 (2-Bromo-alpha-ergocryptine). J. Clin. Endocr. Metab.35, 768 (1972)","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/BF01924949","volume":"28","author":"E. Fl\u00fcckiger","year":"1972","unstructured":"Fl\u00fcckiger, E., Lutterbeck, P. M., Wagner, H. R., Billeter, E.: Antagonism of 2-Bromo-alpha-ergocryptine-methansulfonate (CB 154) to certain endocrine actions of centraly active drugs. Experientia (basle)28, 924 (1972)","journal-title":"Experientia (basle)"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/BF02147804","volume":"24","author":"E. Fl\u00fcckiger","year":"1968","unstructured":"Fl\u00fcckiger, E., Wagner, H. R.: 2-Br-alpha-ergocryptine: Beeinflussung von Fertilit\u00e4t und Laktation hei der Ratte. Experientia24, 1130 (1968)","journal-title":"Experientia"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9378(16)33789-9","volume":"118","author":"P. J. R. Fournier","year":"1974","unstructured":"Fournier, P. J. R., Desjardin, P. D., Friesen, H. G.: Current understanding of human prolactin physiology and its diagnostic and therapeutic applications: A rewiew Amer. J. Obstet. Gynecol.118, 337 (1974)","journal-title":"Amer. J. Obstet. Gynecol."},{"key":"CR10","volume-title":"Human prolactin","author":"A. G. Frantz","year":"1973","unstructured":"Frantz, A. G., Habif, D. V., Hyman, G. A., Suh, K. H., Sassin, J. F., Zimmermann, E. A., Noel, G. L., Kleinberg, D. L.: Physiological and pharmacological factors affecting prolactin secretion, including its suppression by 1-Dopa in the treatment of breast cancer. In: Human prolactin. Pasteels, J. L., Robyn, C., Abling, F. J. G. (eds.) Exerpta med. (Amst.) 273. New York: American Elsevier 1973"},{"key":"CR11","first-page":"527","volume":"28","author":"A. G. Frantz","year":"1972","unstructured":"Frantz, A. G., Kleinberg, D. L., Noel, G. L.: Studies on prolactin in man. Recent Progr. Hormone Res.28, 527 (1972)","journal-title":"Recent Progr. Hormone Res."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0002-9378(71)90581-3","volume":"110","author":"R. D. Gambrell Jr.","year":"1971","unstructured":"Gambrell, R. D. jr., Greenblatt, R. B., Mahesh, V. B.: Post-pill and pill-related amenorrhea-galactorrhea Amer. J. Obstet. Gynecol.110, 838 (1971)","journal-title":"Amer. J. Obstet. Gynecol."},{"key":"CR13","first-page":"1","volume-title":"Fortschritte der Geburtshilfe und Gyn\u00e4kologie, Vol. 52","author":"W. Geiger","year":"1974","unstructured":"Geiger, W.: Methodik und Ergebnisse radioimmunologischer Bestimmungen von HCG, HCS, STH und FSH aus m\u00fctterlichen und kindlichen K\u00f6rperfl\u00fcssigkeiten w\u00e4hrend Schwangerschaft, Geburt und Wochenbett. Fortschritte der Geburtshilfe und Gyn\u00e4kologie, Vol. 52, pp. 1?120. Basel: S. Karger 1974"},{"key":"CR14","first-page":"165","volume":"7","author":"R. B. Greenblatt","year":"1956","unstructured":"Greenblatt, R. B., Carmona, N., Hagler, W. S.: Chiari-Froromel Syndrome. Obstet. Gynecol.7, 165 (1956)","journal-title":"Obstet. Gynecol."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0002-9378(64)90896-8","volume":"88","author":"A. L. Kaskins","year":"1964","unstructured":"Kaskins, A. L., Moszkowski, E. F., Cohen, H.: Chiari-Frommel Syndrome. Medroxy-progesterone Acetate Therapy. Amer. J. Obstet. Gynecol.88, 667 (1964)","journal-title":"Amer. J. Obstet. Gynecol."},{"key":"CR16","first-page":"81","volume-title":"Prolactin and cancerogenesis","author":"L. L'Hermite","year":"1972","unstructured":"L'Hermite, L., Delvoye, P., Nokin, J., Vekemans, M., Robyn, C.: Human prolactin secretion as studied by radioimmunoassay. In: Prolactin and cancerogenesis. Boyns, A. R. K., Griffiths (eds.) 81. Cardiff: Alpha-Omega-Alpha Publishing 1972"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000122042","volume":"9","author":"T. H\u00f6kfelt","year":"1972","unstructured":"H\u00f6kfelt, T., Fuxe, K.: Effects of prolactin and ergotalkaloids on the tuberoinfundibular dopamine neurons. Neuroendocrinology9, 100 (1972)","journal-title":"Neuroendocrinology"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.68.8.1902","volume":"68","author":"P. Hwang","year":"1971","unstructured":"Hwang, P., Guyda, H., Friesen, H.: A radioimmunoassay for human prolactin. Proc. nat. tead. Sci. (Wash)68, 1902 (1971)","journal-title":"Proc. nat. tead. Sci. (Wash)"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1210\/jcem-36-6-1110","volume":"36","author":"P. Hwang","year":"1973","unstructured":"Hwang, P., Robertson, M., Guyda, H., Friesen, H.: The purification of human prolactin from frozen pituitary glands. J. clin. Endocr.36, 1110 (1973)","journal-title":"J. clin. Endocr."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1210\/jcem-34-3-484","volume":"34","author":"L. S. Jacobs","year":"1972","unstructured":"Jacobs, L. S., Mariz, I. K., Daughaday, H. W.: A mixed heterologous radioimmunoassay for human prolactin. J. clin. Endocr.34 484 (1972.)","journal-title":"J. clin. Endocr."},{"key":"CR21","first-page":"59","volume":"34","author":"L. Jaszmann","year":"1974","unstructured":"Jaszmann, L., Stornthal, V.: Fortschritt in der Behandlung des GalaktorrhoeAmenorrhoe-Syndroms: Ovulationsausl\u00f6sung und Hemmung der Milchsekretion mit 2,Br-alpha-Ergocryptin. Geburth. u. Frauenheilk.34, 59 (1974)","journal-title":"Geburth. u. Frauenheilk."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1210\/jcem-33-5-873","volume":"33","author":"D. L. Kleinberg","year":"1971","unstructured":"Kleinberg, D. L., Noel, G. L., Frantz, A. G.: Chlorpromazine Stimulation and 1-Dopa suppression of plasma prolactin in man. J. clin. Endocr.33, 873 (1971)","journal-title":"J. clin. Endocr."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01347142","volume":"216","author":"H. J. K\u00fcnzig","year":"1974","unstructured":"K\u00fcnzig, H. J., Geiger, W.: Radioimmunologic determination of plasma unconjugated estriol in normal and abnormal pregnancies with a specific antiserum to estriol. Arch. Gyn\u00e4k.216, 387 (1974)","journal-title":"Arch. Gyn\u00e4k."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM197211232872110","volume":"287","author":"A. M. Lawrence","year":"1972","unstructured":"Lawrence, A. M., Hagen, T. C.: Ergonovine therapy of non puerperal galactorrhea New. Engl. J. Med.287, 150 (1972)","journal-title":"New. Engl. J. Med."},{"key":"CR25","first-page":"1","volume-title":"Human prolactin","author":"U. J. Lewis","year":"1973","unstructured":"Lewis, U. J., Singh, R. N.: Recovery of prolactin from human pituitary glands. In: Human prolactin. Pasteels, J. L., F. J. G. Ebling, Exerpta med. (Amst.), American Elsevier, New York 1973, S. 1"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/jcem-33-1-153","volume":"33","author":"U. J. Lewis","year":"1971","unstructured":"Lewis, U. J., Singh, R. N. P., Seavey, B. K.: Electrophoretic evidence for human prolactin. J. clin. Endocr.33, 153 (1971)","journal-title":"J. clin. Endocr."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bmj.3.5768.228","volume":"3","author":"P. M. Lutterbeck","year":"1971","unstructured":"Lutterbeck, P. M., Pryor, J. S., Varga, L., Wenner, R.: Treatment of non perperal galactorrhea with an ergot alkaloid. Brit. med. J.3, 228 (1971)","journal-title":"Brit. med. J."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJM197111182852102","volume":"285","author":"W. B. Malarkey","year":"1971","unstructured":"Malarkey, W. B., Jacobs, L. S., Daughaday, W. H.: Levodopa suppression of prolactin in non perperal galactorrhea. New Engl. J. Med.285, 1160 (1971)","journal-title":"New Engl. J. Med."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0083-6729(08)60796-7","volume":"30","author":"J. Meites","year":"1972","unstructured":"Meites, J., Clemens, J. A.: Hypothalamic control of prolactin secretion. Vitam. and Horm.30, 165 (1972)","journal-title":"Vitam. and Horm."},{"key":"CR30","first-page":"471","volume":"28","author":"J. Meites","year":"1972","unstructured":"Meites, J., Lu, K. H., Wuttke, W., Welsch, C. W., Nagasawa, H., Quadri, S. K.: Recent studies on function and control of prolactin secretions in rats. Recent Progr. Hormone Res.28, 471 (1972)","journal-title":"Recent Progr. Hormone Res."},{"key":"CR31","first-page":"188","volume":"37","author":"J. L. Pasteels","year":"1971","unstructured":"Pasteels, J. L., Dauguy, A., Fr\u00e9rotte, M., Ectors, F.: Inhibition de la s\u00e9cr\u00e9tion de prolactine par a l'ergocornine et la 2-Br-alpha-ergocryptine: Action directe sur l'hypophyse en culture. Annales d'Endocrinologie37, 188 (1971)","journal-title":"Annales d'Endocrinologie"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006250-196901000-00001","volume":"33","author":"J. S. Rankin","year":"1969","unstructured":"Rankin, J. S., Goldfarb, A. F., Rakoff, A. E.: Galactorrhea-amenorrhea syndrome: Postpartum galactorrhea in the absence of intracranial neoplasm. Obstet. Gynecol.33, 1 (1969)","journal-title":"Obstet. Gynecol."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2265.1974.tb01791.x","volume":"3","author":"R. Rolland","year":"1974","unstructured":"Rolland, R., Schellekens, L. A., Lequin, R. M.: Successful treatment of galactorrhea and amenorrhea and subsequent restoration of ovarian function by a new ergot alkaloid 2-Brom-alpha-ergocryptine. Clinic. Endocrin.3, 155 (1974)","journal-title":"Clinic. Endocrin."},{"key":"CR34","unstructured":"Schultz, I.: Dissertation (in print)"},{"key":"CR35","first-page":"475","volume":"34","author":"K. D. Schulz","year":"1974","unstructured":"Schulz, K. D.: Prolaktin im Organismus der Frau. Geburtsh. u. Frauenheilk.34, 475 (1974)","journal-title":"Geburtsh. u. Frauenheilk."},{"key":"CR36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/jcem-38-3-508","volume":"38","author":"K. Seki","year":"1974","unstructured":"Seki, K., Seki, M.: Successful ovulation and pregnancy achieved by CB 154 (2-Br-alpha-ergocryptine) in a woman with Chiari-Frommel syndrome. J. Clin. Endocrin. Metab.38, 508 (1974)","journal-title":"J. Clin. Endocrin. Metab."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/BF02135741","volume":"27","author":"H. St\u00e4helin","year":"1971","unstructured":"St\u00e4helin, H., Burckhardt-Vischer, B., Fl\u00fcckiger, E.: Rat mammary cancer inhibition by a prolactin suppressor, 2-Bromo-alpha-ergocryptine (CB 154). Experientia27, 915 (1971)","journal-title":"Experientia"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9378(65)90295-4","volume":"93","author":"J. P. Thompson","year":"1965","unstructured":"Thompson, J. P., Kempers, R. D.: Amenorrhea and galactorrhea. Amer. J. Obstet. Gynecol.93, 65 (1965)","journal-title":"Amer. J. Obstet. Gynecol."},{"key":"CR39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1210\/jcem-34-2-306","volume":"34","author":"R. W. Turkington","year":"1972","unstructured":"Turkington, R. W.: Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with 1-Dopa. J. Clin. Endocr.34, 306 (1972)","journal-title":"J. Clin. Endocr."},{"key":"CR40","first-page":"117","volume":"75","author":"L. Varga","year":"1973","unstructured":"Varga, L., Wenner, R., del Pozo, E.: Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): Restoration of ovulatory function and fertility. Amer. J. Obstet. Gynecol.75, 117 (1973)","journal-title":"Amer. J. Obstet. Gynecol."},{"key":"CR41","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0015-0282(16)39670-4","volume":"24","author":"A. Zarate","year":"1973","unstructured":"Zarate, A., Canales, E. S., Jacobs, L. S., Manerio, J. P., Soria, J., Daughaday, W. H.: Restoration of ovarian function in patients with amenorrhoea-galactorrhoea syndrome after long-term therapy with 1-Dopa. Fertil. Steril.24, 340 (1973)","journal-title":"Fertil. Steril."}],"container-title":["Archiv f\ufffdr Gyn\ufffdkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01395909\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01395909.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01395909\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01395909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T09:47:40Z","timestamp":1556876860000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01395909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975,6]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1975,6]]}},"alternative-id":["BF01395909"],"URL":"https:\/\/doi.org\/10.1007\/bf01395909","relation":{},"ISSN":["0003-9128","1432-0711"],"issn-type":[{"value":"0003-9128","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[1975,6]]}}}